Evolent Health, Inc. (EVH)

Market Cap	2.24B
Revenue (ttm)	2.18B
Net Income (ttm)	-141.23M
Shares Out	116.21M
EPS (ttm)	-1.26
PE Ratio	n/a
Forward PE	13.26
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,216,917
Open	18.46
Previous Close	18.41
Day's Range	18.31 - 19.52
52-Week Range	17.98 - 35.00
Beta	1.44
Analysts	Strong Buy
Price Target	41.75 (+116.88%)
Earnings Date	Jul 31, 2024

About EVH

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care wor...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jun 5, 2015
• Employees: 4,700
• Stock Exchange: NYSE
• Ticker Symbol: EVH

Financial Performance

In 2023, Evolent Health's revenue was $1.96 billion, an increase of 45.26% compared to the previous year's $1.35 billion. Losses were -$142.26 million, 642.3% more than in 2022.

Analyst Forecast

According to 8 analysts, the average rating for EVH stock is "Strong Buy." The 12-month stock price forecast is $41.75, which is an increase of 116.88% from the latest price.

Price Target

$41.75

(116.88% upside)

Analyst Consensus: Strong Buy